LA
EBS icon

Lee Ainslie’s Emergent Biosolutions EBS Stock Holding History

Lee Ainslie’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,858
Closed -$293K – 414
2021
Q3 		$293K Buy
5,858
+5,569
+1,927% +$337K ﹤0.01% 498
2021
Q2 		$18K Buy
+289
New +$18.6K ﹤0.01% 657
2021
Q1 		– Sell
-2,364
Closed -$212K – 756
2020
Q4 		$212K Buy
+2,364
New +$217K ﹤0.01% 520

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lee Ainslie's EBS Position: Q4 2021 in Review

Lee Ainslie sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 5,858 shares — an estimated $293K sold.

Lee Ainslie first reported a position in EBS in Q4 2020 and held it in 3 quarters. The position peaked at $293K in Q3 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Lee Ainslie reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Lee Ainslie sold 5,858 Emergent Biosolutions shares in Q4 2021, an estimated $293K.
  • Lee Ainslie first reported a position in Emergent Biosolutions in Q4 2020 and held it in 3 quarters.
  • Lee Ainslie's Emergent Biosolutions position peaked at $293K in Q3 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.